Mechanisms of acquired resistance to cetuximab: role of HER (ErbB) family members
2008 · Oncogene · 546 citations
https://doi.org/10.1038/onc.2008.19
D
Deric L. Wheeler
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
243
Papers
6.2K
Citations
42
h-index
72
i10-index
Deric L. Wheeler is an academic researcher from University of Wisconsin–Madison. The author has contributed to research in topics: Phagocytosis and Immune Regulation & Lung Cancer Treatments and Mutations & HER2/EGFR in Cancer Research. The author has an h-index of 42, co-authored 207 publications.
ORCID: 0000-0001-5915-3675Papers by this author
worksMechanisms of resistance to HER family targeting antibodies
2010 · Experimental Cell Research · 140 citations
https://doi.org/10.1016/j.yexcr.2010.01.009
Overcoming acquired resistance to cetuximab by dual targeting HER family receptors with antibody-based therapy
2014 · Molecular Cancer · 64 citations
https://doi.org/10.1186/1476-4598-13-242
Activation of AKT by hypoxia: a potential target for hypoxic tumors of the head and neck
2012 · BMC Cancer · 63 citations
https://doi.org/10.1186/1471-2407-12-463
Akt1 and Akt3 but not Akt2 through interaction with DNA-PKcs stimulate proliferation and post-irradiation cell survival of K-RAS-mutated cancer cells
2017 · Cell Death Discovery · 45 citations
https://doi.org/10.1038/cddiscovery.2017.72
Targeting the HER Family with Pan-HER Effectively Overcomes Resistance to Cetuximab
2016 · Molecular Cancer Therapeutics · 44 citations
https://doi.org/10.1158/1535-7163.mct-16-0012
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat